In recent years, the U.S. FDA has approved several TLR adjuvanted vaccines, including TLR4 based HPV vaccine (Cerarix) and zoster vaccine (Shingrix), and TLR9 based HBV vaccine (Heplisav). The gene discussed is TLR9; the disease is herpes zoster.